Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on December 24th, 2012% The U.S. Food and Drug Administration on Friday approved the prescription of oseltamivir phosphate to treat acute, uncomplicated influenza in children as young as two weeks in age. Oseltamivir phosphate, developed by Genentech, a division of the pharmaceutical company Roche in South San Francisco, California, is marketed under the brand name Tamiflu.
Tamiflu blocks the . . . → Read More: FDA Extends Flu Therapy Approval for Infants
By Alan, on December 21st, 2012% A new challenge on InnoCentive asks for a simple, reusable, and inexpensive timing mechanism based on the principles of reverse fluid flow and color change, with a total purse of $50,000. This type of competition — called a reduction-to-practice challenge — requires a written description and evidence of a working prototype, with one-page abstracts due . . . → Read More: $50,000 Challenge Seeks Simple, Inexpensive Timer
By Alan, on December 21st, 2012% (National Institutes of Health)
OncoMed Pharmaceuticals Inc., a biotechnology company in Redwood City, California, began dosing patients enrolled in a clinical trial of its therapy addressing cancer stem cells. The phase 1 trial is testing OMP-52M51, a monoclonal antibody — a type of engineered antibody molecule — designed for patients with hematologic cancers, . . . → Read More: Clinical Trial Underway for Cancer Stem Cell Therapy
By Alan, on December 21st, 2012% Engineers at Massachusetts Institute of Technology and University of California at Berkeley devised a method for locating sources of urban traffic jams with anonymous data from cell phone records, which can encourage more effective strategies for reducing congestion. The team led by MIT civil and environmental engineering professor Marta González reported its findings in yesterday’s . . . → Read More: Cell Phone, GPS Data Identify Urban Traffic Jam Sources
By Alan, on December 20th, 2012% Sharon Gerecht (Will Kirk, Homewood Photography/Johns Hopkins University)
Biomedical engineers at Johns Hopkins University in Baltimore developed a process that causes stem cells to transform into two different types of tissue found in the walls of blood vessels. The findings of the team led by chemical and biomolecular engineering professor Sharon Gerecht are . . . → Read More: Stem Cells Induced to Become Blood Vessel Tissue Cells
By Alan, on December 20th, 2012% Konstantin Novoselov (University of Manchester)
The universities of Manchester, Cambridge, and Lancaster in the U.K. received funding from the European Research Council to develop new two-dimensional materials similar to graphene. The €13.4 million ($US17.7 million) grant was awarded to the three institutions under the council’s Synergy Grant initiative.
The universities will form what . . . → Read More: U.K. Universities Form Advanced Materials Consortium
By Alan, on December 20th, 2012% (National Institute of Drug Abuse)
Biogen Idec, a biotechnology company in Weston, Massachusetts, will collaborate with researchers from Yale, Harvard, Columbia, and Rockefeller universities to identify new treatment strategies for amyotrophic lateral sclerosis (ALS). The company says it is committing $10 million over three years to the research consortium.
ALS, also known as . . . → Read More: Biogen Idec, Four Universities Partner on ALS Therapies
By Alan, on December 19th, 2012% Thin-film solar cells can be fashioned into roof-top tiles or shingles. (National Renewable Energy Laboratory)
A new research and development project led by North Carolina State University in Raleigh seeks to reduce the time and cost of installing rooftop solar energy systems. The five-year, $9 million grant was awarded by the U.S. Department . . . → Read More: R&D Project Aims To Cut Time, Cost of Solar Installations
By Alan, on December 19th, 2012% Research on artificial intelligence by a professor at Gothenberg University in Sweden made possible a machine that sorts discarded household batteries and a company that developed and markets the system. Claes Strannegård, a researcher in logic and cognitive science at Gothenberg, applied his work on artificial intelligence to find a better way of sorting garbage.
. . . → Read More: University Research Leads to Battery Sorting Machine
By Alan, on December 19th, 2012% Patient enters a PET scanner (National Institute of Mental Health)
The pharmaceutical company Merck and GE Healthcare, the medical technologies unit of General Electric, are collaborating in a clinical trial of Merck’s drug candidate for the treatment of Alzheimer’s disease. The trial is testing Merck’s compound known as MK-8931, a beta amyloid precursor . . . → Read More: Merck, GE Healthcare Partner on Alzheimer’s Treatment Trial
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|
You must be logged in to post a comment.